Nevertheless, previous immunohistochemical studies addressing the role of macrophages in tumour microenvironment have largely relied on the use of CD68 and/or CD163 only and have considered CD163 to be a marker of M2 macrophages. The gene discussed is CD163; the disease is neoplasm.